Shenzhen
China
6
2024-06-06
2
2025-09-30
These are the the leading inventors for applications assigned to SHENZHEN ENDURING BIOTECH, LTD.:
SHENZHEN ENDURING BIOTECH, LTD. based in Shenzhen, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PEGYLATED T CELL ENGAGER WITH DUAL SPECIFICITIES TO CD3 AND CD19
#2 | 2023-12-07LONG ACTING BI-SPECIFIC T CELL ENGAGERS TARGETING CD3 AND CD47
#3 | 2023-04-06ANTIBODY-DRUG CONJUGATE
#4 | 2022-07-28BISPECIFIC T-CELL ENGAGER WITH CLEAVABLE CYTOKINES FOR TARGETED IMMUNOTHERAPY
#5 | 2021-11-04 ✅ Patent 12,427,203 granted on 2025-09-30Long Acting Multi-Specific Molecules And Related Methods
#6 | 2019-10-03 ✅ Patent 11,065,342 granted on 2021-07-20Long acting multi-specific molecules and related methods
Also check out Shenzhen Enduring Biotech, Ltd.'s (Shenzhen, China) applicant profile with 3 patent applications submitted.
326386 ⎘